Efficacy of adalimumab for Crohn’s disease in real clinical practice

Efficacy of adalimumab for Crohn’s disease in real clinical practice

Aim. To evaluate the efficacy and safety of adalimumab (ADA) in patients with Crohn’s disease (CD) treated at the Department of Inflammatory Bowel Diseases, Moscow Clinical Research and Practical Center, and to determine the predictors of a therapy response. Subjects and methods. All the patients wi...

Full description

Bibliographic Details
Main Authors: O V Knyazev, A V Kagramanova, I N Ruchkina, N A Fadeeva, A A Lishchinskaya, O N Boldyreva, E Yu Zhulina, P L Shcherbakov, N V Orlova, M V Kirova, A I Parfenov
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2017-02-01
Series:Терапевтический архив
Subjects:
adalimumab
infliximab
crohn’s disease
luminal form
perianal form
clinical remission
complete healing of the intestinal mucosa
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/32155/pdf

Internet

https://ter-arkhiv.ru/0040-3660/article/viewFile/32155/pdf

Similar Items